Abstract
Rheumatoid arthritis (RA) is a debilitating chronic disease, characterized by inflammation of synovial joint tissue, exhibiting symptoms such as pain, swelling and muscle fatigue, which can lead to the destruction of the joints. Non-steroidal anti-inflammatory drugs (NSAIDs), such as ketoprofen (KET), are widely used for symptomatic treatment of rheumatic diseases, including RA. However, …